SHREE GANESH REMEDIES LTD.
Market Cap.(`)
|
772.76 Cr.
|
P/BV
|
5.80
|
Book Value (`)
|
103.70
|
52 Week High/Low ( ` )
|
950/573
|
FV/ML
|
10/1
|
P/E(X)
|
33.50
|
Book Closure
|
09/02/2024
|
EPS (`)
|
17.97
|
Div Yield (%)
|
0.00
|
You can view the
Consolidated
Ratio Analysis
for the last 5 years.
Months | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | |
PER SHARE RATIOS | | | | |
| | | | |
Basic EPS (Rs.) | 17.96 | 22.34 | 11.67 | 6.95 |
Diluted EPS (Rs.) | 17.96 | 22.34 | 11.67 | 6.95 |
Cash EPS (Rs.) | 25.42 | 26.64 | 14.23 | 8.11 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 113.07 | 95.07 | 47.09 | 37.70 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 113.07 | 95.07 | 47.09 | 37.70 |
Revenue From Operations / Share (Rs.) | 84.59 | 98.02 | 71.36 | 39.36 |
PBDIT / Share (Rs.) | 33.45 | 34.94 | 18.31 | 11.04 |
PBIT / Share (Rs.) | 26.00 | 30.18 | 15.75 | 9.89 |
PBT / Share (Rs.) | 24.36 | 29.71 | 15.15 | 9.66 |
Net Profit / Share (Rs.) | 17.97 | 21.89 | 11.67 | 6.95 |
NP After MI And SOA / Share (Rs.) | 17.97 | 21.89 | 11.67 | 6.95 |
| | | | |
PROFITABILITY RATIOS | | | | |
| | | | |
PBDIT Margin (%) | 39.54 | 35.64 | 25.65 | 28.05 |
PBIT Margin (%) | 30.73 | 30.79 | 22.07 | 25.11 |
PBT Margin (%) | 28.79 | 30.31 | 21.22 | 24.54 |
Net Profit Margin (%) | 21.24 | 22.32 | 16.35 | 17.65 |
NP After MI And SOA Margin (%) | 21.24 | 22.32 | 16.35 | 17.65 |
Return on Networth / Equity (%) | 15.89 | 23.02 | 24.81 | 18.43 |
Return on Capital Employeed (%) | 18.98 | 25.46 | 31.47 | 25.67 |
Return On Assets (%) | 12.01 | 16.44 | 18.94 | 15.08 |
Long Term Debt / Equity (X) | 0.20 | 0.23 | 0.05 | 0.01 |
Total Debt / Equity (X) | 0.26 | 0.29 | 0.10 | 0.01 |
Asset Turnover Ratio (%) | 0.59 | 0.00 | 1.25 | 0.00 |
| | | | |
LIQUIDITY RATIOS | | | | |
| | | | |
Current Ratio (X) | 4.79 | 3.76 | 3.26 | 3.80 |
Quick Ratio (X) | 3.43 | 2.42 | 2.64 | 2.84 |
Inventory Turnover Ratio (X) | 1.59 | 0.00 | 5.91 | 0.00 |
Dividend Payout Ratio (NP) (%) | 0.00 | 2.22 | 12.91 | 17.39 |
Dividend Payout Ratio (CP) (%) | 0.00 | 1.82 | 10.59 | 14.91 |
Earning Retention Ratio (%) | 0.00 | 97.78 | 87.09 | 82.61 |
Cash Earning Retention Ratio (%) | 0.00 | 98.18 | 89.41 | 85.09 |
| | | | |
COVERAGE RATIOS | | | | |
| | | | |
Interest Coverage Ratio (%) | 20.38 | 73.91 | 30.28 | 48.54 |
Interest Coverage Ratio (Post Tax) (%) | 11.95 | 47.29 | 20.30 | 31.54 |
| | | | |
VALUATION RATIOS | | | | |
| | | | |
Enterprise Value (Cr.) | 941.29 | 877.09 | 67.03 | 48.15 |
EV / Net Operating Revenue (X) | 8.67 | 6.97 | 1.05 | 1.36 |
EV / EBITDA (X) | 21.92 | 19.54 | 4.08 | 4.86 |
MarketCap / Net Operating Revenue (X) | 8.41 | 6.81 | 1.02 | 1.38 |
Retention Ratios (%) | 0.00 | 97.77 | 87.08 | 82.60 |
Price / BV (X) | 6.29 | 7.02 | 1.54 | 1.44 |
Price / Net Operating Revenue (X) | 8.41 | 6.81 | 1.02 | 1.38 |
EarningsYield | 0.02 | 0.03 | 0.16 | 0.12 |